Search In this Thesis
   Search In this Thesis  
العنوان
Study of Serum Irisin in patients with Thyroid Dysfunction /
المؤلف
Mohamed ,Mohamed Samir
هيئة الاعداد
باحث / محمد سمير محمد
مشرف / محمد هشام الجيار
مشرف / خالد محمود مقبول
مشرف / أحمد محمد بهاء الدين
تاريخ النشر
2017
عدد الصفحات
144.p:
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
علم الغدد الصماء والسكري والأيض
تاريخ الإجازة
1/1/2017
مكان الإجازة
جامعة عين شمس - كلية الطب - Endocrinology and Metabolism
الفهرس
Only 14 pages are availabe for public view

from 144

from 144

Abstract

fibronectin type III domain-containing protein 5 (FNDC5), is a novel myokine secreted by contracting skeletal muscle, possibly mediating some exercise health benefits via ‘browning’ of white adipose tissue. Irisin can causes a significant increase in total body energy expenditure and resistance to obesity-associated insulin resistance in mice, while controversy still exists concerning irisin origin, regulation and function in humans.
Objective: Aim of our study was to study relation of thyroid status (hypo, hyperthyroid) with serum irisin, ck and peripheral neuropathy.
Methods: Our study was conducted on 60 candidates consisted of 40 patients with thyroid dysfunction selected from endocrine outpatient clinic and inpatient department of Ain Shams University Hospitals and 20 healthy volunteers from April 2016 to October 2016. Informed consent was obtained from all participants. Patients of both gender, of age more than 18 years old, 20 patients with hypothyroidism, 20 patients with hyperthyroidism and 20 healthy volunteers. We excluded Significant renal, hepatic and cardiac disease, severe associated acute illness or depression, Pregnant females,diabetes, hypercortisolism, hypocortisolism, muscular or neurological disorders, routinely taking drugs as statins, intensively involved in a sport or any strenuous physical activity. All participants were subjected to full medical history taking, General clinical examination and Laboratory investigations as thyroid and thyroid-related hormone concentrations and as well as a thyroid ultrasound examination and thyroid scan for patients with hyperthyroidism. Serum irisin level, CK and nerve conduction velocity.
Results: Irisin level was higher in hyperthyroid group than euthyroid group with a significant difference. In comparison of normal NCV candidates and reduced NCV candidates with other variables there is only border line significant difference with irisin p-value. Non significant value of irisin and CK level for diagnosis of hypothyroidism. Irisin has highly significant value for diagnosis of hyperthyroidism with (sen 95%, sp 42.5). Increase of BMI is the only independent predictor for hypothyroidism by using Multivariable binary logistic regression analysis. Decrease of BMI and irisin are independent predictors for hyperthyroidism.
Conclusion: Serum irisin level is one of predictors for hyperthyroidism, on the other hand irisin does not have a significant value to predict hypothyroidism. Serum irisin was found to be higher in patients with hyperthyroidism in comparison to euthyroid participant with non statistically significant difference between hypo and hyperthyroidism. Serum CK level does not have a significant value in diagnosis of thyroid dysfunction (hypothyroidism or hyperthyroidism). Serum irisin level was low in thyroid dysfunction cases with delayed NCV compared to thyroid dysfunction cases with normal NCV with border line significant difference.